The CDSCO has identified 84 batches of drugs, including commonly prescribed steroids and cholesterol medications, as 'not-of-standard quality' during recent inspections. This alert aims to ensure the removal of substandard drugs from the market. The CDSCO regularly monitors drug quality and has introduced new guidelines for inspectors to enhance sampling efficiency. Inspectors are now required to collect at least 10 samples monthly, ensuring timely forwarding to laboratories for testing. The initiative is part of ongoing efforts to safeguard public health by identifying and eliminating non-standard and spurious medicines.

A woman in Mangaluru suffered severe complications after a surgical mop was left inside her during a C-section. Two months later, a CT scan revealed the negligence, leading to an emergency surgery to remove the mop. The woman experienced significant pain and was unable to breastfeed her newborn. Her husband reported the incident to the National Consumer Grievance portal and expressed their distress over the situation and the financial burden of treatment. Health officials have promised a thorough investigation into the matter.

Andrew Wilkinson, co-founder of Tiny, expressed shock at DocuSign's pricing, prompting a response from Zoho's Sridhar Vembu. Vembu criticized DocuSign as a bloated company and suggested that businesses evaluate SaaS vendors based on their sales and marketing expenses compared to R&D. He argued that if a company spends significantly more on selling than on developing its product, it may be overcharging. Vembu also dismissed the idea that sales and marketing could serve as a competitive advantage, citing the success of open-source solutions in enterprise markets.